4//SEC Filing
Holdbrook Mark J. 4
Accession 0001827564-22-000002
CIK 0001819790other
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 4:13 PM ET
Size
7.7 KB
Accession
0001827564-22-000002
Insider Transaction Report
Form 4
Holdbrook Mark J.
V.P., Clinical Affairs
Transactions
- Award
Stock Option (right to buy)
2022-03-09+36,173→ 36,173 totalExercise: $19.59Exp: 2032-03-08→ Common Stock (36,173 underlying) - Award
Restricted Stock Units
2022-03-09+10,612→ 10,612 total→ Common Stock (10,612 underlying)
Footnotes (3)
- [F1]25% of the option shares shall vest on March 9, 2023, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001827564
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 7:00 PM ET
- Accepted
- Mar 11, 4:13 PM ET
- Size
- 7.7 KB